Ascendis Pharma is a fast-growing global biopharmaceutical company committed to making a meaningful difference in patients’ lives. We have locations in Denmark, Germany, the United States, the UK, Italy, Spain, and France. Guided by our core values of Patients, Science, and Passion, we use our TransCon® drug development platform to fulfil our mission of developing new therapies, selecting only those that demonstrate best-in-class potential to address unmet medical needs. Today, we are advancing programs in Endocrinology Rare Disease and Oncology. In addition, we collaborate with partners around the world on the development of TransCon-based products for other therapeutic areas and markets.